Top compounds associated with response to CRYZL1


Feature Type Standardized
Nominal ANOVA
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.0031 0.9
mRNA masitinib CTRPv2 pan-cancer AAC 0.0031 0.9
mRNA WP1130 CTRPv2 pan-cancer AAC 0.0028 0.9
mRNA AT-406 CTRPv2 pan-cancer AAC -0.0035 0.9
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.0026 0.9
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0024 0.9
mRNA PX-12 CTRPv2 pan-cancer AAC 0.0017 1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0022 1
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.0029 1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0019 1
Download CSV